Psychosocial Support for Patients With Takotsubo Syndrome
Launched by WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY · Jul 27, 2023
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether joining a virtual support group can help patients with Takotsubo Syndrome feel less anxious over the course of a year. Takotsubo Syndrome, sometimes called "broken heart syndrome," is a condition that can cause temporary heart muscle problems, often triggered by stressful events. The researchers believe that connecting with others who are going through similar experiences can improve mental well-being.
To participate in this study, you need to be at least 18 years old and have a confirmed diagnosis of Takotsubo Syndrome. However, if you are already receiving therapy for emotional support or belong to certain groups, like pregnant women or non-English speakers, you won’t be eligible to join. If you take part, you can expect to engage in online meetings with other patients, share experiences, and receive support to help manage anxiety. The goal is to see if this type of support can make a positive difference in your emotional health over time.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - All patients with documented diagnosis of Takotsubo Syndrome greater than 18 years old.
- Exclusion Criteria:
- • Patients with a diagnosis of Takotsubo Syndrome already undergoing Psychotherapy or those who choose not to participate.
- • Vulnerable populations such as prisoners, non-English speaking subjects, pregnant women, and subjects unable to provide written informed consent will not be included in this research.
About Weill Medical College Of Cornell University
Weill Medical College of Cornell University is a leading academic institution dedicated to advancing medical research and education. As a prominent sponsor of clinical trials, it focuses on innovative healthcare solutions and the development of new therapies across various medical disciplines. The institution is committed to fostering collaborative research efforts that enhance patient care and improve health outcomes. With a robust infrastructure and a team of experienced researchers and clinicians, Weill Cornell aims to translate scientific discoveries into practical applications, ensuring a strong emphasis on ethical standards and regulatory compliance throughout the clinical trial process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Jim Cheung, MD
Principal Investigator
Weill Medical College of Cornell University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported